Tiny lab study probes Mepolizumab's effect on sinus cells

NCT ID NCT05895929

Recruiting now Knowledge-focused Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jan 12, 2026 · Last updated May 23, 2026 · Updated 12 times

Summary

This early-stage lab study uses nasal cells from people with chronic sinusitis and nasal polyps to see how the drug mepolizumab affects inflammation and cell barrier health. The study is small (8 participants) and takes place in a lab, not in patients directly. It aims to understand how the drug works at a cellular level.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Johns Hopkins Bayview Medical Center
RECRUITING

Baltimore, Maryland, 21117, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Johns Hopkins Hospital
RECRUITING

Baltimore, Maryland, 21287, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CHRONIC RHINOSINUSITIS (DIAGNOSIS) CHRONIC RHINOSINUSITIS WITH NASAL POLYPS